This article was originally published in The Tan Sheet
Zeller heads FDA tobacco center; FDA denies P&G diabetes claim; Meda depends on OTCs; Ocean Nutrition boosts DSM; Elcelyx innovates in financing round; FDA warns DMAA firm on GMP violations; probiotics get Canadian claim approval.
You may also be interested in...
Mitch Zeller retires more than 30 year career in tobacco policy; Logan Tucker joins CHPA communications director; GOED hires Ashely Becnel as global business development director; ACI VP Kathleen Stanton appointed to Industry Trade advisory committee.
Hi-Tech absorbs hit from Sandy; Meda strikes MidNite deal; Sunscreen labeling due date nears; ChromaDex picks up Spherix Consulting; Chemi Pharmaceutical allegedly falsified tests; Actavis exec Boothe joins Perrigo.
Kellogg Co. disagrees with ConAgra’s petition to FDA for a qualified health claim linking whole grain consumption with reduced risk of type 2 diabetes. Other experts question ConAgra’s supporting evidence and maintain fiber content should be emphasized over whole grains in product labeling.